Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
Provided By GlobeNewswire
Last update: Jun 18, 2025
WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced the appointment of Rita Jain, M.D. to its Board of Directors.
Read more at globenewswire.com
